Cannovex – Developing Cannabinoid-Based Medicines

Developing

cannabinoid-based medicines

to improve patients’ lives

Cannovex BV provides pharmacies with the highest purity cannabidiol (CBD) as Active Pharmaceutical Ingredient.

CANNABINOIDS

Cannabinoids are a class of molecules that hold much promise in healthcare. Their pharmacological action in the human body is based on interaction with cannabinoid receptors, most notably cannabinoid receptor type 1 and cannabinoid receptor type 2.

Company

We are a next-generation biotech company, focused on the research, development and commercialisation of novel EMA and FDA- approved cannabinoid-based medicines that we bring to market through partnerships.

Pipeline

Our pipeline of innovative cannabinoid formulations and proprietary drug delivery systems targets the improvement of the quality of life of patients with various conditions in which there is a high unmet medical need.

Latest news

CANNOVEX receives EUR 0.5 million grant for development of nanofibrous films for transmucosal uptake of cannabinoids.

cannovexOctober 14, 2020

Diepenbeek, Belgium, 14 October 2020 – Cannovex BV (the ‘Company’ or ‘Cannovex), a developer of cannabinoid-based medicines today announces that it has been awarded a EUR 0.5 million development grant…

Mission

Cannovex envisages to set up clinical studies to provide Proofs of Concept, to be followed by end-stage clinical trials in partnership with pharmaceutical companies to evidence the safety and efficacy of the selected cannabinoid drug candidates and apply for market authorisation with EMA and FDA thus paving the path to the market.

Our Story

Since its inception in 2016, Cannovex has merited the position as the designated conversation partner, sounding board and source of information on cannabinoid medicines. Following a quick scan of medical literature on the subject, the founders of Cannovex decided to create a venture to develop cannabinoid-based medicines.

team

Expertise and excellence in Corporate Strategy, Finance, Science and Entrepreneurship as well as the passion to improve patients’ lives by developing safe, reliable and effective cannabinoid-based medicines, characterize the members of our Board of Directors and our Management Team.

Industry concepts of cannabinoid-BASED medicines

Medicinal cannabis, cannabinoid-based medicine,… what’s in a name?
This infographic provides an overview of the various concepts.
Cannovex is focusing on concept 4.0 – i.e. the development of cannabinoid-based medicines.

Our Partners

Cannovex has entered into partnerships with universities and institutions for scientific research and business development, both in Belgium as in The Netherlands. Cannovex is open for partnerships to accomplish its mission to improve patients’ lives by developing cannabinoid-based medicines.